Investigate Scientifically Potential Abilities in Cells

CORPORATE MESSAGE en

  • TOP
  • CORPORATE MESSAGE en

Message from the CEO

We founded our company in January 2017 with the mission to develop and commercialize revolutionary treatments for diseases that remain incurable with existing therapies. By leveraging outstanding research and cutting-edge technologies, we aim to create innovative therapeutic solutions that not only treat diseases but also restore high quality of life (QOL)*1 through novel drugs with superior efficacy and safety profiles.
*1 QOL=Quality of Life (the degree of physical, mental, and intellectual satisfaction in daily living)

Our mission sets us apart from large pharmaceutical companies that prioritize developing treatments for high-volume markets. Instead, we are committed to addressing rare and intractable diseases that have been overlooked due to their limited patient populations. By leveraging cutting-edge technologies, we challenge ourselves to develop innovative therapies and deliver the treatments that patients desperately need.

Japan established a world-leading foundation in medical and pharmaceutical research by the 1990s, producing numerous outstanding research achievements that have been shared globally. Despite having sufficient infrastructure to advance industry through scientific innovation and contribute to human health—even as a resource-limited nation—Japan has had limited opportunities to generate world-first breakthrough drugs. This may be partly attributed to the lack of a flexible social environment (including regulatory frameworks and market structures) necessary to translate groundbreaking medical research into practical applications.

However, recent regulatory reforms in Japan have accelerated dramatically, including the enactment of new regenerative medicine legislation and revisions to pharmaceutical regulations. The introduction of drug development promotion systems comparable to those in Europe and the United States, along with the consolidation of medical research budgets, has created unprecedented momentum for the medical application of innovative advanced technologies without being constrained by conventional thinking. This environment now enables research and development of cell therapies, gene therapies, and other treatments based on fundamental medical science.

代表メッセージ

We view these environmental changes as an exceptional opportunity for our mission to commercialize cutting-edge technologies in the medical field.
Our company aims to develop new drugs by integrating our accumulated expertise in medical and pharmaceutical research and development, adhering to scientifically data-driven drug development standards under Japan’s Pharmaceuticals and Medical Devices Act. Our mission is to challenge the development of breakthrough treatments for intractable and rare diseases that have remained incurable, utilizing state-of-the-art technologies. Our founding vision at CellAxia is to deliver truly needed therapies to patients.

Makoto Seki Ph.D.
President and CEO
CellAxia Inc.

The Vision Behind Our Company Name

The name “CellAxia Inc.” combines “cell” with “axia”, derived from the Greek word meaning “valuable” or “worthy.” This reflects our commitment to creating cells of exceptional value and significance in the field of regenerative medicine.

The human body consists of 30 trillion cells, each serving a specific role in maintaining the health and functionality of organs and bodily systems. Disease arises when the delicate balance of intercellular crosstalk is disrupted. Under the following mission statements, we pursue the development of therapeutics that not only cure intractable diseases but also restore health by normalizing internal balance through revitalizing the function of damaged cell populations — essentially restoring cells that have lost their original function.

・A company that explores the scientific potential of cellular capabilities
・A company that harnesses cellular potential for medical applications
・A company that maximizes the value of cells

By constantly embracing the vision embedded in our company name, we strive to deliver the breakthrough drugs that patients suffering from incurable rare and intractable diseases have long awaited.